Innovent Biologics, Inc.

SEHK:1801 Stok Raporu

Piyasa değeri: HK$60.6b

Innovent Biologics Yönetim

Yönetim kriter kontrolleri 1/4

Innovent Biologics CEO'su Michael Yu, Jan2011 tarihinde atandı, in görev süresi 13.83 yıldır. in toplam yıllık tazminatı CN¥ 36.44M olup, şirket hissesi ve opsiyonları dahil olmak üzere 7.9% maaş ve 92.1% ikramiyelerden oluşmaktadır. şirketin hisselerinin 6.53% ine doğrudan sahiptir ve bu hisseler HK$ 3.96B değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 0.8 yıl ve 3.3 yıldır.

Anahtar bilgiler

Michael Yu

İcra Kurulu Başkanı

CN¥36.4m

Toplam tazminat

CEO maaş yüzdesi7.9%
CEO görev süresi13.8yrs
CEO sahipliği6.5%
Yönetim ortalama görev süresiless than a year
Yönetim Kurulu ortalama görev süresi3.3yrs

Son yönetim güncellemeleri

Shareholders May Not Be So Generous With Innovent Biologics, Inc.'s (HKG:1801) CEO Compensation And Here's Why

Jun 14
Shareholders May Not Be So Generous With Innovent Biologics, Inc.'s (HKG:1801) CEO Compensation And Here's Why

Recent updates

Shareholders May Not Be So Generous With Innovent Biologics, Inc.'s (HKG:1801) CEO Compensation And Here's Why

Jun 14
Shareholders May Not Be So Generous With Innovent Biologics, Inc.'s (HKG:1801) CEO Compensation And Here's Why

Innovent Biologics, Inc. (HKG:1801) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

May 01
Innovent Biologics, Inc. (HKG:1801) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

There's Reason For Concern Over Innovent Biologics, Inc.'s (HKG:1801) Massive 27% Price Jump

Feb 28
There's Reason For Concern Over Innovent Biologics, Inc.'s (HKG:1801) Massive 27% Price Jump

Are Investors Undervaluing Innovent Biologics, Inc. (HKG:1801) By 33%?

Jan 12
Are Investors Undervaluing Innovent Biologics, Inc. (HKG:1801) By 33%?

Innovent Biologics, Inc.'s (HKG:1801) Price Is Out Of Tune With Revenues

Dec 25
Innovent Biologics, Inc.'s (HKG:1801) Price Is Out Of Tune With Revenues

An Intrinsic Calculation For Innovent Biologics, Inc. (HKG:1801) Suggests It's 34% Undervalued

Sep 11
An Intrinsic Calculation For Innovent Biologics, Inc. (HKG:1801) Suggests It's 34% Undervalued

Is There An Opportunity With Innovent Biologics, Inc.'s (HKG:1801) 50% Undervaluation?

Jun 04
Is There An Opportunity With Innovent Biologics, Inc.'s (HKG:1801) 50% Undervaluation?

Benign Growth For Innovent Biologics, Inc. (HKG:1801) Underpins Its Share Price

May 14
Benign Growth For Innovent Biologics, Inc. (HKG:1801) Underpins Its Share Price

Innovent Biologics, Inc. (HKG:1801) Shares Could Be 50% Below Their Intrinsic Value Estimate

Dec 27
Innovent Biologics, Inc. (HKG:1801) Shares Could Be 50% Below Their Intrinsic Value Estimate

CEO Tazminat Analizi

Michael Yu'un ücretlendirmesi Innovent Biologics'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-CN¥1b

Mar 31 2024n/an/a

-CN¥1b

Dec 31 2023CN¥36mCN¥3m

-CN¥1b

Sep 30 2023n/an/a

-CN¥1b

Jun 30 2023n/an/a

-CN¥1b

Mar 31 2023n/an/a

-CN¥2b

Dec 31 2022CN¥33mCN¥3m

-CN¥2b

Sep 30 2022n/an/a

-CN¥2b

Jun 30 2022n/an/a

-CN¥3b

Mar 31 2022n/an/a

-CN¥3b

Dec 31 2021CN¥26mCN¥3m

-CN¥3b

Sep 30 2021n/an/a

-CN¥2b

Jun 30 2021n/an/a

-CN¥1b

Mar 31 2021n/an/a

-CN¥1b

Dec 31 2020CN¥105mCN¥3m

-CN¥998m

Sep 30 2020n/an/a

-CN¥1b

Jun 30 2020n/an/a

-CN¥2b

Mar 31 2020n/an/a

-CN¥2b

Dec 31 2019CN¥76mCN¥3m

-CN¥2b

Tazminat ve Piyasa: Michael 'nin toplam tazminatı ($USD 5.03M ), Hong Kong pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 887.73K ).

Tazminat ve Kazançlar: Michael şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.


CEO

Michael Yu (60 yo)

13.8yrs

Görev süresi

CN¥36,444,000

Tazminat

Dr. De-Chao Yu, also known as Michael, Ph.D. Co-Founded Innovent Biologics, Inc. in August 2011 and has been its Chairman and Chief Executive Officer since 2011. He served as its President at Innovent Biol...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
De-Chao Yu
Co-Founder13.8yrsCN¥36.44m6.53%
HK$ 4.0b
Hao Xi Ede
Executive Director & Fund Managing Partnerless than a yearCN¥7.10m0.20%
HK$ 120.5m
Fei You
Chief Financial Officerless than a yearVeri yokVeri yok
Vivian Zhang
Chief People Officer5.3yrsVeri yok0.020%
HK$ 12.4m
Min Liu
Chief Commercial Officerno dataVeri yokVeri yok
Dongming Wang
Senior Vice President4.8yrsVeri yokVeri yok
Blake Salisbury
Senior Vice Presidentno dataVeri yokVeri yok
Hui Zhou
Senior Vice Presidentless than a yearVeri yokVeri yok
Nageatte Ibrahim
Oncology Chief Medical Officerless than a yearVeri yokVeri yok
Samuel Suhua Zhang
Global Chief Business Officerless than a yearVeri yokVeri yok
Raj Dhodda
Senior Vice Presidentless than a yearVeri yokVeri yok
Lei Qian
Senior Vice Presidentless than a yearVeri yokVeri yok

0.8yrs

Ortalama Görev Süresi

53.5yo

Ortalama Yaş

Deneyimli Yönetim: 1801 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 0.8 yıl), bu da yeni bir ekibin varlığını gösteriyor.


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
De-Chao Yu
Co-Founder13.8yrsCN¥36.44m6.53%
HK$ 4.0b
Hao Xi Ede
Executive Director & Fund Managing Partnerno dataCN¥7.10m0.20%
HK$ 120.5m
Vivian Zhang
Chief People Officerless than a yearVeri yok0.020%
HK$ 12.4m
Charles Leland Cooney
Member of CMC Strategic Advisory Board & Independent Non-Executive Director9.1yrsCN¥400.00k0.0028%
HK$ 1.7m
Lewis Lanier
Member of Scientific Advisory Board3.3yrsVeri yokVeri yok
I-Yin Hsu
Independent Non-Executive Director6.1yrsCN¥400.00k0.00039%
HK$ 236.4k
Erwin Vanhaecke
Member of CMC Strategic Advisory Boardno dataVeri yokVeri yok
Kai-Xian Chen
Independent Non-Executive Director6.1yrsCN¥400.00k0.00033%
HK$ 200.0k
David LaPre
Member of CMC Strategic Advisory Boardno dataVeri yokVeri yok
Shuyun Chen
Independent Non-Executive Directorless than a yearVeri yok0.00067%
HK$ 406.0k
Lawrence Fong
Member of Scientific Advisory Board3.3yrsVeri yokVeri yok
Carlos Garcia-Echeverria
Member of Scientific Advisory Board3.3yrsVeri yokVeri yok

3.3yrs

Ortalama Görev Süresi

60yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 1801 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.3 yıldır).